Chinese medical devices maker SyMap Medical has secured nearly $100 million in a new funding round jointly led by Hong Kong-based financial services provider VMS Group and private equity (PE) firm Primavera Capital Group.

In November 2018, the firm raised 70 million yuan ($11 million) in a Series C round from Ming Bioventures and Kington Capital. SyMap will use the fresh capital to fund the global clinical trials of existing pipeline products, R&D of new-generation RDN devices, as well as potential acquisition of overseas innovative technologies and products.

China’S Rdn Medical Device Maker Symap Raises Nearly $100M

Description

Company Information

Funding Insights

China’S Rdn Medical Device Maker Symap Raises Nearly $100M

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information